Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
92.13
-0.64 (-0.69%)
At close: Sep 18, 2026, 4:00 PM EDT
92.40
+0.27 (0.29%)
After-hours: Sep 18, 2026, 7:55 PM EDT
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Cardiovascular
14.62B13.98B13.51B13.09B12.76B12.48B12.28B12.17B
Cardiovascular Growth
14.55%11.96%10.08%7.61%6.43%5.49%2.27%2.71%
Neuroscience
10.15B10.29B10.16B10.06B9.95B9.85B9.77B9.67B
Neuroscience Growth
2.06%4.48%3.94%4.01%4.63%4.67%5.38%5.49%
Medical Surgery
9.41B8.82B8.64B8.54B8.50B8.41B8.39B8.47B
Medical Surgery Growth
10.77%4.84%2.92%0.80%0.13%-1.40%-0.70%0.33%
Diabetes
3.23B3.11B3.00B2.90B2.83B2.76B2.69B2.63B
Diabetes Growth
14.28%12.92%11.72%10.14%10.64%10.73%10.90%11.90%
Other
130.00M174.00M171.00M171.00M173.00M48.00M74.00M59.00M
Other Growth
-24.86%262.50%131.08%189.83%293.18%-57.14%34.55%55.26%
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
18.78B18.10B17.78B17.52B17.31B17.17B16.97B16.85B
United States Growth
8.50%5.43%4.80%4.01%3.54%3.67%1.62%1.27%
Rest of World
18.76B18.26B17.70B17.23B16.89B16.37B16.23B16.15B
Rest of World Growth
11.07%11.58%9.06%6.74%6.51%3.58%3.90%5.40%
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Selling, General, and Administrative
12.18B11.78B11.45B11.21B11.00B10.85B10.89B10.85B
Selling, General, and Administrative Growth
10.67%8.60%5.09%3.31%2.06%1.05%2.89%3.04%
Research and Development
2.92B2.87B2.89B2.84B2.78B2.73B2.72B2.74B
Research and Development Growth
4.89%5.16%5.99%3.50%1.38%-0.15%0.81%1.82%
Amortization
1.73B1.77B1.93B1.90B1.85B1.81B1.66B1.67B
Amortization Growth
-6.86%-1.94%15.94%14.23%10.44%6.80%-2.00%-2.52%
Other Expenses
440.00M387.00M142.00M102.00M46.00M-23.00M439.00M461.00M
Other Expenses Growth
856.52%--67.65%-77.87%-90.09%-920.93%-
Restructuring
277.00M250.00M279.00M245.00M265.00M267.00M232.00M209.00M
Restructuring Growth
4.53%-6.37%20.26%17.22%21.00%18.14%-43.14%-50.94%
Litigation
85.00M112.00M303.00M263.00M263.00M317.00M147.00M125.00M
Litigation Growth
-67.68%-64.67%106.12%110.40%38.42%112.75%96.00%66.67%